Compared efficacy of preservation solutions in liver transplantation: A long-term graft outcome study from the european liver transplant registry

American Journal of Transplantation

Volumn 15, Issue 2, 2015, Pages 395-406

  Adam, R ^a   Delvart, V ^a   Karam, V ^a   Ducerf, C ^b   Navarro, F ^c   Letoublon, C ^d   Belghiti, J ^e   Pezet, D ^f   Castaing, D ^a   Le Treut, Y P ^g   Gugenheim, J ^h   Bachellier, P ⁱ   Pirenne, J ^j   Muiesan, P ^k  

^a HÔPITAL PAUL BROUSSE   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e BEAUJON HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k QUEEN ELIZABETH HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; PRESERVATION SOLUTION; ADENOSINE; ALLOPURINOL; CELSIOR; DISACCHARIDE; ELECTROLYTE; GLUCOSE; GLUTAMIC ACID DERIVATIVE; GLUTATHIONE; HISTIDINE; HTK SOLUTION; IGL-1 SOLUTION; INSULIN; MANNITOL; POTASSIUM CHLORIDE; PROCAINE; RAFFINOSE; UNIVERSITY OF WISCONSIN-LACTOBIONATE SOLUTION;

ADULT; ARTICLE; CAUSE OF DEATH; DISEASE REGISTRY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT PRESERVATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LIVER CIRRHOSIS; LIVER GRAFT; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPERFUSION INJURY; RISK FACTOR; CLINICAL TRIAL; COMPARATIVE STUDY; EUROPE; GRAFT REJECTION; INCIDENCE; LIVER; LONGITUDINAL STUDY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PROCEDURES; REGISTER; RETROSPECTIVE STUDY;

ADENOSINE; ADULT; ALLOPURINOL; DISACCHARIDES; ELECTROLYTES; EUROPE; FEMALE; GLUCOSE; GLUTAMATES; GLUTATHIONE; GRAFT REJECTION; GRAFT SURVIVAL; HISTIDINE; HUMANS; INCIDENCE; INSULIN; LIVER; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MANNITOL; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; RAFFINOSE; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 84921500396     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13060     Document Type: Article

References (25)

1. Casillas-Ramírez A, Mosbah IB, Ramalho F, Rosellõ-Catafau J, Peralta C., Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006; 79: 1881-1894.
2. Zaouali MA, Ben Abdennebi H, Padrissa-Altés S, Mahfoudh-Boussaid A, Rosellõ-Catafau J., Pharmacological strategies against total ischemia reperfusion injury. Expert Opin Pharmacother 2010; 11: 537-555.
3. Lee CY, Mangino MJ., Preservations methods for kidney and liver. Organogenesis 2009; 5: 105-112.
4. O'Callagan JM, Morgan RD, Night SR, Morris PJ., Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplantation outcomes. Br J Surg 2013; 100: 991-1001.
5. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: The first clinical series. Am J Transplant 2010; 10: 372-381.
6. Ferrigno A, Rizzo V, Boncompagni E, et al. Machine perfusion at 20°C reduces preservation damage to livers from non-heart beating donors. Cryobiology 2011; 62: 152-158.
7. Schlegel A, Graf R, Clavien PA, Dutkowski P., Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation. J Hepatol 2013; 59: 984-991.
8. Jamieson RW, Zilvetti M, Roy D, et al. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model. Transplantation 2011; 92: 289-295.
9. Fondevila C, Hessheimer AJ, Maathuis MH, et al. Superior preservation of DCD livers with continuous normothermic perfusion. Ann Surg 2011; 254: 1000-1007.
10. O'Callaghan JM, Morgan RD, Knight SR, Morris PJ., The effect of preservation solutions for storage of liver allografts on transplant outcomes: A sytematic review and meta-analysis. Ann Surg 2014; 260: 46-55.
11. Karam V, Gunson B, Roggen F, et al. Quality control of the European Liver Transplant Registry: Results of audit visits to the contributing centers. Transplantation 2003; 75: 2167-2173.
12. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: Report of the European Liver Transplant Registry. Liver Transpl 2003; 9: 1231-1243.
13. Stewart ZA, Cameron AM, Singer AL, Montgomery RA, Segev DL., Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009; 9: 286-293.
14. Mangus RS, Fridell JA, Vianna RM, et al. Comparison of histidinetryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl 2008; 14: 365-373.
15. Nardo B, Bertelli R, Montalti R, et al. Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation. Transplant Proc 2005; 37: 320-322.
16. Dondéro F, Paugam-Burtz C, Danjou F, Stocco J, Durand F, Belghiti J., A randomized study comparing IGL-1 to the University of Wisconsin preservation solution in liver transplantation. Ann Transplant 2010; 15: 7-14.
17. Feng XN, Xu X, Zheng SS., Current status and erspective of liver preservation solutions. Hepatobiliary Pancreat Dis Int 2006; 5: 490-494.
18. Puhl G, Olschewski P, Schoning W, et al. Low viscosity histidine-tryptophan-ketoglutarate graft flush improves subsequent extended cold storage in University of Wisconsin solution in an extracorporeal rat liver perfusion and rat liver transplantation model. Liver Transpl 2006; 12: 1841-1849.
19. Belzer FO, Southard JH., Principles of solid-organ preservation by cold storage. Transplantation 1988; 45: 673-676.
20. 't Hart NA, Leuvenink HG, Ploeg RJ., New solutions in organ preservation. Transplant Rev 2002; 16: 131-141.
21. Ramalho FS, Fernandez-Monteiro I, Rosello-Catafau J, Peralta C., Hepatic microcirculatory failure. Acta Cir Bras 2006; 1: 48-53.
22. Janssen H, Janssen PH, Broelsch CE., UW is superior to Celsior and HTK in the protection of human liver endothelial cells against preservation injury. Liver Transpl 2004; 10: 1514-1523.
23. Straatsburg IH, Abrahamse SL, Song SW, Hartman RJ, Van Gulik TM., Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior. Transplantation 2002; 74: 458-464.
24. Abrahamse SL, van Runnard Heimel P, Hartman RJ, Chamuleau RA, van Gulik TM., Induction of necrosis and DNA fragmentation during hypothermic preservation of hepatocytes in UW, HTK, and Celsior solutions. Cell Transplant 2003; 12: 59-68.
25. Padrissa-Altés S, Zaoualí MA, Rosellõ-Catafau J., AMP-activated protein kinase as a target for preconditioning in transplantation medicine. Transplantation 2010; 90: 1241.